Valuation Atossa Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 00:00:00 12/09/2026 +04			5-day change	1st Jan Change
2.510 ^USD	+7.26%		-0.40%	-71.64%

08-07	Atossa Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-28	Atossa Therapeutics Announces Publication of Novel (Z)-Endoxifen-Related Compounds Demonstrating Potent Anti-Cancer Activity in Er-Positive Breast Cancer	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	202.6	66.92	110.3	118.8	76.21	25.05	-	-
Change	-	-66.97%	64.77%	7.71%	-35.83%	-67.13%	-	-
Enterprise Value (EV)	202.6	66.92	110.3	118.8	76.21	25.05	25.05	25.05
Change	-	-66.97%	64.77%	7.71%	-35.83%	-67.13%	0%	0%
P/E	-8.89x	-2.52x	-3.67x	-4.72x	-2.19x	-0.65x	-0.8x	0.92x
PBR	1.47x	0.57x	1.22x	1.69x	1.92x	-	-	-
PEG	-	-0.2x	-0.3x	0.3x	-0.1x	0.13x	0x	-0x
Capitalization / Revenue	-	-	-	-	-	-	-	0.21x
EV / Revenue	-	-	-	-	-	-	-	0.21x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-0.7x	-0.66x	0.51x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-2.7	-3.15	-3.6	-3	-4.04	-3.84	-3.143	2.715
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	-	-	-	-	-	118.7
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-20.52	-27.69	-31.38	-27.62	-37.14	-35.88	-38.03	49.46
Net income ¹	-20.61	-26.96	-30.09	-25.5	-34.77	-34.89	-38.03	49.46
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	24.000	7.927	13.200	14.161	8.850	2.510	2.510	2.510
Nbr of stocks (in thousands)	8,442	8,442	8,354	8,387	8,611	9,979	-	-
Announcement Date	28/02/22	22/03/23	01/04/24	25/03/25	25/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ATOSSA THERAPEUTICS, INC.	-0.65x	-	-	-	25.05M
LONZA GROUP AG	31.04x	5.6x	16.76x	1.05%	45.48B
REVOLUTION MEDICINES, INC.	-20.85x	240.83x	-22.36x	-.--%	43.68B
IQVIA HOLDINGS INC.	33.71x	3.27x	14.1x	-.--%	43.09B
BEONE MEDICINES AG	45.39x	5.23x	28.64x	-.--%	39.4B
CELLTRION, INC.	27.03x	8.15x	20.66x	0.42%	31.91B
MEDPACE HOLDINGS, INC.	33.41x	5.47x	24.85x	-.--%	16.4B
EUROFINS SCIENTIFIC SE	23.57x	2.06x	8.94x	1.13%	14.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	74.44x	3.94x	15.27x	-.--%	13.28B
Average	27.46x	34.32x	13.36x	0.33%	27.5B
Weighted average by Cap.	26.17x	46.68x	11.79x	0.31%